期刊文献+

辛伐他汀对糖尿病大鼠血脂和血小板膜糖蛋白表达水平的影响 被引量:3

Effect of simvastatin on the expression of platelet membrane glycoprotein in diabetic rats
下载PDF
导出
摘要 目的探讨羟甲基戊二酸单酰辅酶A(HMG-CoA)还原酶抑制剂辛伐他汀对2型糖尿病大鼠血脂和血小板膜糖蛋白表达的影响。方法雌性Wistar大鼠腹腔注射链脲佐菌素(STZ)建立糖尿病模型,造模成功后将其随机分为糖尿病组、辛伐他汀组[辛伐他汀混悬液灌胃,20 mg/(kg·d),共用12周]各10只,另取10只健康大鼠设为对照组,12周后测定及比较各组血脂及血小板膜糖蛋白CD62p、CD63、CD61、CD41的表达。结果糖尿病组总胆固醇、甘油三酯和LDL水平高于对照组,而HDL的水平低于对照组(P<0.01);辛伐他汀组总胆固醇、甘油三酯和LDL水平低于糖尿病组,而HDL水平高于糖尿病组(P<0.01);糖尿病组血小板膜糖蛋白CD62p和CD63水平较对照组高(P<0.01),辛伐他汀组的CD62p和CD63水平较糖尿病组低(P<0.01);3组血小板膜糖蛋白CD61、CD41水平比较差异无统计学意义(P>0.05)。结论辛伐他汀能调节糖尿病大鼠的血脂水平,能降低血小板膜糖蛋白CD62p和CD63的水平,抑制血小板的聚集。 Objective To investigate the effect of simvastatin on serum lipids and the expression of platelet membrane glycoproteins in diabetic rats. Methods Type 2 diabetes model was established in female Wistar rats by intraperitoneal injection of streptozotocin. Diabetic rats were randomly divided into diabetic group (n=10)and simvastin group [n=10,received simvastatin gavaging for 12 weeks ,20 mg/(kg&#183;d)],10 healthy normal rats were selected as control group. Flow cytometric analysis was applied to detect the expression of CD62p,CD63,CD61 and CD41 on the surface of platelet after 12 weeks of treatment.Result Compared with control group,the serum levels of total cholesterol (TC),triglyceride (TG)and low density lipoprotein (LDL)were increased significantly in diabetic group but the serum level of high density lipoprotein (HDL) was decreased (P&lt;0.01). The serum levels of TC,TG and LDL in simvastin group were lower than those of diabetic group,but the level of HDL level was higher (P&lt;0.01). The expressions of CD62p and CD63 on the surface of platelet in diabetic group were higher than those of control group (P&lt;0.01),but simvastatin signifi-cantly decreased their expressions in diabetic rats (P&lt;0.01). However,there was no difference in the expres-sions of CD61 and CD41 among three groups. Conclusion Simvastatin can regulate serum lipids and decrease the expressions of CD62p and CD63 on the surface of platelet in diabetic rats,and then inhibit aggregation of platelet.
出处 《新医学》 2014年第4期236-239,共4页 Journal of New Medicine
关键词 糖尿病 血小板膜糖蛋白 辛伐他汀 Diabetes mellitus Platelet membrane glycoprotein Simvastatin
  • 相关文献

参考文献12

  • 1Kaplon-Cieslicka A,Rosiak M,Postuta M,et al. Pre-dictors of high platelet reactivity during aspirin treatmentin patients with type 2 diabetes. Kardiol Pol, 2013,71: 893-902.
  • 2Pastuszczak M, Kotlarz A,Mostowik M. et al. Priorsimvastatin treatment is associated with reduced throm-bin generation and platelet activation in patients with a-cute ST-segment elevation myocardial infarction. ThrombRes, 2010,125: 382-386.
  • 3Lundstrom A,Laska AC, Von Arbin M,et al. Glucoseintolerance and insulin resistance as predictors of lowplatelet response to clopidogrel in patients with minor is-chemic stroke or TIA. Platelets, 2014,25: 102-110.
  • 4Balestrieri ML, Servillo L, Esposito A, et al. Poor gly-caemic control in type 2 diabetes patients reduces endo-thelial progenitor cell number by influencing SIRT1 sig-nalling via platelet-activating factor receptor activation.Diabetologia, 2013,56: 162-172.
  • 5Chandler AB,Earhart AD,Speich HE,et al. Regula-tion of CD40L ( CD154) and CD62P ( p-selectin) sur-face expression upon GPIIb-IIIa blockade of plateletsfrom stable coronary artery disease patients. ThrombRes, 2010, 125: 44-52.
  • 6Dunkel B, Rickards KJ, Werling D,et al. Neutrophiland platelet activation in equine recurrent airway ob-struction is associated with increased neutrophil CD 13expression, but not platelet CD41/61 and CD62P orneutrophil- platelet aggregate formation. Vet ImmunolImmunopathol, 2009 , 131 : 25-32.
  • 7Stellos K,Bigalke B,Stakos D. et al. Platelet-bound P~selectin expression in patients with coronary artery dis-ease :impact on clinical presentation and myocardialnecrosis,and effect of diabetes mellitus and anti-plateletmedication. J Thromb Haemost, 2010,8: 205-207.
  • 8El-Mesallamy H,Hamdy N,Suwailem S,et al. Oxida-tive stress and platelet activation : markers of myocardialinfarction in type 2 diabetes mellitus. Angiology, 2010,61; 14-18.
  • 9Mobarrez F,He S, Broijersen A,et al. Atorvastatin re-duces thrombin generation and expression of tissue fac-tor, P-selectin and GPIIIa on platelet-derived micropar-ticles in patients with peripheral arterial occlusive dis-ease. Thromb Haemost, 2011,106: 344-352.
  • 10Gocmen AY, Ocak GA, Ozbilim G,et al. Effect ofatorvastatin on atherosclerotic plaque formation andplatelet activation in hypercholesterolemic rats. Can JPhysiol Pharmacol, 2013 , 91: 680-685.

同被引文献33

  • 1陈可冀.血瘀证与活血化瘀治疗的研究[J].中国中医药现代远程教育,2005,3(11):10-12. 被引量:123
  • 2时晶,田金洲,王永炎,朱爱华,尹军祥,武月萍,徐意.血瘀证的生物学基础研究[J].中华中医药杂志,2006,21(6):363-364. 被引量:83
  • 3陆再英,钟南山.内科学.7版.北京:人民卫生出版社,2008,1:267-294.
  • 4吴以岭,魏聪,贾振华,朱昭明.从络病学说探讨糖尿病肾病的病机[J].中国中医基础医学杂志,2007,13(9):659-660. 被引量:86
  • 5Rodrigues ML, Motta ME. Mechanisms and factors as- sociated with gastrointestinal symptoms in patients with diabetes mellitus. J Pediatr ( Rio J), 2012, 88 ( 1 ) : 17-24.
  • 6Tan DW, Barker N. Intestinal stem cells and their defi- ning niche. Curt Top Dev Biol, 2014, 107: 77-107.
  • 7Min XH, Yu T, Qing Q, Yuan YH, Zhong W, Chen GC, Zhao LN, Deng N, Zhang LF, Chen QK. Abnor- mal differentiation of intestinal epithelium and intestinal harrier dysfunction in diabetic mice associated with de- pressed Notch/NICD transduction in Notch/Hesl signal pathway. Cell Biol Int, 2014, 38 (10) : 1194-1204.
  • 8Campbell CF. Isolation and culture of mouse intestinal cells. Methods Mol Biol, 2010, 633: 197-206.
  • 9Zhao J, Chen P, Gregersen H. Morpho-mechanical in-testinal remodeling in type 2 diabetic GK rats-is it relat- ed to advanced glycation end product formation. J Bio- mech, 2013, 46 (6) : 1128-1134.
  • 10Peeters PJ, Bazelier MT, Leufkens HG, de Vries F, De Bruin ML. The Risk of Colorectal Cancer in Patients With Type 2 Diabetes: Associations With Treatment Stage and Obesity. Diabetes Care, 2015, 38 ( 3 ) : 495 -502.

引证文献3

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部